BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15173495)

  • 1. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease.
    Ekekezie II; Thibeault DW; Simon SD; Norberg M; Merrill JD; Ballard RA; Ballard PL; Truog WE
    Pediatrics; 2004 Jun; 113(6):1709-14. PubMed ID: 15173495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress.
    Cederqvist K; Sorsa T; Tervahartiala T; Maisi P; Reunanen K; Lassus P; Andersson S
    Pediatrics; 2001 Sep; 108(3):686-92. PubMed ID: 11533337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression profiles in tracheal aspirates do not adequately reflect tracheal or lung tissue profiles in neonatal respiratory distress: observations from an animal model.
    Miller TL; Touch SM; Shaffer TH
    Pediatr Crit Care Med; 2006 Jan; 7(1):63-9. PubMed ID: 16395077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia.
    Tambunting F; Beharry KD; Hartleroad J; Waltzman J; Stavitsky Y; Modanlou HD
    Pediatr Pulmonol; 2005 Jan; 39(1):5-14. PubMed ID: 15521085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of tissue inhibitor of metalloproteinase-2 at birth may be associated with subsequent development of bronchopulmonary dysplasia in preterm infants.
    Lee C; An J; Kim JH; Kim ES; Kim SH; Cho YK; Cha DH; Han MY; Lee KH; Sheen YH
    Korean J Pediatr; 2015 Nov; 58(11):415-20. PubMed ID: 26692876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers.
    Ladwig GP; Robson MC; Liu R; Kuhn MA; Muir DF; Schultz GS
    Wound Repair Regen; 2002; 10(1):26-37. PubMed ID: 11983004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease.
    Sweet DG; Curley AE; Chesshyre E; Pizzotti J; Wilbourn MS; Halliday HL; Warner JA
    Acta Paediatr; 2004 Jun; 93(6):791-6. PubMed ID: 15244229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative differences in matrix metalloproteinase (MMP)-2, but not in MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 or TIMP-2, in seminal plasma of normozoospermic and azoospermic patients.
    Baumgart E; Lenk SV; Loening SA; Jung K
    Hum Reprod; 2002 Nov; 17(11):2919-23. PubMed ID: 12407049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates.
    Schulz CG; Sawicki G; Lemke RP; Roeten BM; Schulz R; Cheung PY
    Pediatr Res; 2004 May; 55(5):794-801. PubMed ID: 14973177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases (MMP-1, MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in oral submucous fibrosis.
    Rajendran R; Rajeesh MP; Shaikh S; Shanthi ; Pillai MR
    Indian J Dent Res; 2006; 17(4):161-6. PubMed ID: 17217211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
    Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
    Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
    Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis.
    Letra A; Ghaneh G; Zhao M; Ray H; Francisconi CF; Garlet GP; Silva RM
    J Endod; 2013 Sep; 39(9):1141-6. PubMed ID: 23953287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
    Brun JL; Cortez A; Lesieur B; Uzan S; Rouzier R; Daraï E
    Oncol Rep; 2012 Apr; 27(4):1049-57. PubMed ID: 22200690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
    Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
    J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma.
    Jo Chae K; Rha SY; Oh BK; Koo JS; Kim YJ; Choi J; Park C; Park YN
    Am J Gastroenterol; 2004 Jan; 99(1):68-75. PubMed ID: 14687144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
    Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.